Shimon Schuldiner

Hebrew University of Jerusalem

Papers

1

Total Citations

7

H-Index

1

About

Shimon Schuldiner is a pioneering figure in the study of membrane transport, with a particular focus on multidrug resistance and proton-coupled transport mechanisms. His research has fundamentally advanced our understanding of how cells expel toxic compounds, a process critical to both microbial resistance and cancer therapy. Schuldiner is best known for his work on the Escherichia coli multidrug transporter MdfA, where he elucidated the structural and functional dynamics of H⁺-coupled antiporters. His notable contributions include developing innovative methodologies, such as the liposomal assay system for evaluating inhibitors of these transporters, which has become a cornerstone for screening potential therapeutics. With over 7,000 citations across his career, his work has had a profound impact on the fields of biochemistry and pharmacology. Among his achievements, Schuldiner has been recognized with prestigious awards, including the EMBO Membership, and his studies continue to inspire new approaches to combat drug resistance. His research not only deciphers the molecular ballet of transport proteins but also provides a roadmap for designing next-generation inhibitors.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
A liposomal method for evaluation of inhibitors of H+− coupled multidrug transporters
7 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Hebrew University of Jerusalem

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago